Skip to main content

Table 4 Body weight in the beginning (day 1), middle (day 7) and final (day 15) of the treatment and food intake of the control groups (CS and CV200) and Ehrlich tumor groups (TS and TV200)

From: Vochysia tucanorum Mart. butanol fraction presents antitumoral activity in vivo and prevents the installation of cachexia in solid Ehrlich tumor model

  Day 1 (g) Day 7 (g) Day 15 (g) Weight ratio
(%)
Food intake (g/100 g)
CS 47.05 ± 1.29 49.86 ± 1.43 49.91 ± 1.34 + 6.07 18.11 ± 0.37
CV200 46.79 ± 0.91 48.27 ± 0.91 48.95 ± 0.61 + 4.61 20.22 ± 1.25
TS 47.56 ± 1.24 48.98 ± 1.15 44.96 ± 1.14 −5.46 19.4 ± 0.8
TV200 46.92 ± 1.51 48.25 ± 1.65 49.93 ± 1.82 + 6.41 18.49 ± 0.51
  1. CS (Control animals treated with saline); CV200 (Control animals treated with 200 mg/kg Fr-BuVt); TS (Ehrlich carcinoma-bearing mice treated with saline); TV200 (Ehrlich carcinoma-bearing mice treated with 200 mg/kg Fr-BuVt). Values are expressed as means ± SEM. There are no significative differences, ANOVA followed by Holm-Sidak post hoc test.